RecruitingPhase 3Other

Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs

Sponsored by Assiut University

NCT ID
NCT04928300
Target Enrollment
60 participants
Start Date
2021-06-12
Est. Completion
2027-07-25

About This Study

In our study, we assess the diaphragmatic function, pain quality and anti-inflammatory properties between low dose infusion of dexmedetomidine normal saline in patients with multiple fracture ribs on conservative treatment.

Conditions Studied

Rib Fractures

Interventions

  • Dexmedetomidine
  • 0.9% saline

Eligibility

Age:18 Years - 65 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Adults (age 18-65 years) of American Society of Anaesthesiologists (ASA) physical status I-II
* Traumatic multiple fracture ribs 3 ribs or more, who will be subjected to thorough assessments including chest 3D-CT
* Undergoing conservative treatment (chest strappings)
* Intractable pain with visual analogue scale (VAS) over 6 after traditional therapies
* Glasgow Coma Scale (GCS) ≥ 13.

Exclusion Criteria:

* Multiple traumas to body parts other than chest with an abbreviated injury scale over 3
* Serious head trauma with a Glasgow coma scale lower than 13
* Mechanically ventilated patients
* Massive hemothorax
* Injury to the trachea or bronchus with requirement for immediate surgery
* Dementia
* Use of corticosteroids during ICU stay
* Sepsis
* Continued use of neuromuscular blocking agents and aminoglycosides antibiotic use as they are known risk factors for ICU-acquired weakness and any known hypersensitivity
* Contraindication to the study drugs.

Study Locations (1)

Assiut university hospital
Asyut, Assuit, Egypt

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Omar Soliman, MD
CONTACT
01101266040omarmakram347@yahoo.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs | Huxley